About
ProSciento has a dedicated Pharmaceutical Services (PS) Group that oversees investigational product (IP) management and related specialized services for multicenter, multinational metabolic clinical trials for biopharmaceutical clients worldwide. The PS Group consists of pharmacists and researchers with longstanding expertise in clinical research and stable isotope tracer studies.
Recommended Materials
Posters
Effect of Dawn Phenomenon on Glucose Infusion Rate During Glucose Clamp Studies In Subjects with Type 1 Diabetes
Posters
DA-1241 a novel GPR119 agonist: Safety, tolerability, pharmacokinetics, and pharmacodynamics: Part 2 of multiple ascending dose study in type 2 diabetes patients
Posters
The novel glucagon receptor agonist SAR438544, first in human safety, pharmacokinetic and pharmacodynamic data from a study in healthy volunteers
Related Solutions
Specialized Methods
